VTYX - CIK 0001851194
Ventyx Biosciences, Inc. trades as VTYX and has a market capitalization of $1.00 B, making it the #2638 largest US-listed company by market value. This page tracks Ventyx Biosciences, Inc. through 495 SEC filings, with financial statements and metrics updated as new reports are filed.
| Filing | Type | Filed |
|---|---|---|
| SCHEDULE 13G/A | - | 2026-05-15 |
| SCHEDULE 13G/A | - | 2026-05-14 |
| SCHEDULE 13G/A | - | 2026-05-14 |
| 15-12G | - | 2026-03-16 |
| EFFECT | - | 2026-03-06 |
| EFFECT | - | 2026-03-06 |
| SCHEDULE 13D/A | - | 2026-03-05 |
| Insider trade | 4 | 2026-03-04 |
Lilly and our partners use cookies to operate our site that are always on and for other optional analytics, personalization, and marketing. Accept or Reject optional cookies. To modify your choice and for more details, see Cookie Settings. For more information see our Privacy Statement.
Lilly and our partners use cookies to operate our site that are always on and for other optional analytics, personalization, and marketing. Accept or Reject optional cookies. To modify your choice and for more details, see Cookie Settings. For more information see our Privacy Statement.
Lilly and our partners use cookies to operate our site that are always on and for other optional analytics, personalization, and marketing. Accept or Reject optional cookies. To modify your choice and for more details, see Cookie Settings. For more information see our Privacy Statement.
Lilly and our partners use cookies to operate our site that are always on and for other optional analytics, personalization, and marketing. Accept or Reject optional cookies. To modify your choice and for more details, see Cookie Settings. For more information see our Privacy Statement.
The largest companies sharing Ventyx Biosciences, Inc.'s SEC industry classification (pharmaceutical preparations).
Ventyx Biosciences, Inc. (VTYX) has a market capitalization of $1.00 B as of 2026-05-29, ranking #2638 among US-listed companies.
In its latest fiscal year Ventyx Biosciences, Inc. reported a net loss of $135.12M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
Dig into the full income statement, balance sheet, and cash flow statement with annual and quarterly views.